These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 13424483)
1. Comparative protein repletion in cancer and non-cancer cachexia with special reference to changes in blood volume and total circulating plasma protein and hemoglobin. PEDEN JC; BOND LF; MAXWELL M Am J Clin Nutr; 1957; 5(3):305-15. PubMed ID: 13424483 [No Abstract] [Full Text] [Related]
2. Thyroid hormones in conditions of chronic malnutrition. A study with special reference to cancer cachexia. Persson H; Bennegård K; Lundberg PA; Svaninger G; Lundholm K Ann Surg; 1985 Jan; 201(1):45-52. PubMed ID: 3917657 [TBL] [Abstract][Full Text] [Related]
3. L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia. Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Aleksandrowicz-Wrona E; Jankun J; Lysiak-Szydłowska W Oncol Rep; 2012 Jul; 28(1):319-23. PubMed ID: 22562434 [TBL] [Abstract][Full Text] [Related]
4. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Penafuerte CA; Gagnon B; Sirois J; Murphy J; MacDonald N; Tremblay ML Br J Cancer; 2016 Mar; 114(6):680-7. PubMed ID: 26954714 [TBL] [Abstract][Full Text] [Related]
5. Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia. Ebadi M; Mazurak VC Mediators Inflamm; 2015; 2015():820934. PubMed ID: 26508820 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of B-cell activating factor in paediatric patients with malignancy with or without cancer-related cachexia. Bienertova-Vasku J; Lungova A; Bienert P; Zlamal F; Tomandl J; Tomandlova M; Splichal Z; Sterba J Klin Onkol; 2012; 25 Suppl 2():2S58-63. PubMed ID: 23581018 [TBL] [Abstract][Full Text] [Related]
7. Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients. Naito T; Tashiro M; Ishida T; Ohnishi K; Kawakami J J Clin Pharmacol; 2013 Aug; 53(8):812-8. PubMed ID: 23733622 [TBL] [Abstract][Full Text] [Related]
8. [Pre- and postoperative blood volume, total circulating hemoglobin and blood proteins in cancer of the stomach]. FRETHEIM B Nord Med; 1955 Mar; 53(13):517-23. PubMed ID: 14384025 [No Abstract] [Full Text] [Related]
10. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. Garcia JM; Garcia-Touza M; Hijazi RA; Taffet G; Epner D; Mann D; Smith RG; Cunningham GR; Marcelli M J Clin Endocrinol Metab; 2005 May; 90(5):2920-6. PubMed ID: 15713718 [TBL] [Abstract][Full Text] [Related]
11. Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients. Iwase S; Murakami T; Saito Y; Nakagawa K Eur Cytokine Netw; 2004; 15(4):312-6. PubMed ID: 15627639 [TBL] [Abstract][Full Text] [Related]
12. Adipokines in patients with cancer anorexia and cachexia. Smiechowska J; Utech A; Taffet G; Hayes T; Marcelli M; Garcia JM J Investig Med; 2010 Mar; 58(3):554-9. PubMed ID: 20215915 [TBL] [Abstract][Full Text] [Related]
13. Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients. Sato H; Naito T; Ishida T; Kawakami J Eur J Clin Pharmacol; 2016 Dec; 72(12):1463-1470. PubMed ID: 27566315 [TBL] [Abstract][Full Text] [Related]
14. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Batista ML; Olivan M; Alcantara PS; Sandoval R; Peres SB; Neves RX; Silverio R; Maximiano LF; Otoch JP; Seelaender M Cytokine; 2013 Feb; 61(2):532-9. PubMed ID: 23200412 [TBL] [Abstract][Full Text] [Related]